Loading the player...


INFO:
From the 2022 San Antonio Breast Cancer Symposium (SABCS), Paolo Tarantino, MD, from Dana-Farber Cancer Institute updates patients with HER2-low disease.
What Have We Learned About HER2-Low Breast Cancer?